Literature DB >> 17332972

Combination of transverse myelitis and arachnoiditis in cauda equina syndrome of long-standing ankylosing spondylitis: MRI features and its role in clinical management.

Howard Haw-Chang Lan1, Der-Yuan Chen, Clayton Chi-Chang Chen, Joung-Liang Lan, Chia-Wei Hsieh.   

Abstract

The cauda equina syndrome (CES) is a rare neurological complication of ankylosing spondylitis (AS). Imaging diagnosis of CES in long-standing AS patients (CES-AS) using myelography, computed tomography (CT), and magnetic resonance imaging (MRI) were reported in the literature. They, however, demonstrate only the chronic abnormalities of CES-AS, i.e., dural ectasia, dorsal dural diverticula, and selective bone erosion at the posterior elements of the vertebrae. To our knowledge, imaging features of acute intradural inflammation in CES-AS were not described. We report a patient of CES-AS in whom MRI disclosed acute transverse myelitis and arachnoiditis along the lower spinal cord, and discuss the pathogenesis of CES-AS and the role of MRI in clinical management.

Entities:  

Mesh:

Year:  2007        PMID: 17332972     DOI: 10.1007/s10067-007-0593-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Cauda Equina Lesions Associated with Ankylosing Spondylitis.

Authors:  E A Bowie; G L Glasgow
Journal:  Br Med J       Date:  1961-07-01

2.  Transverse myelitis in a patient with long-standing ankylosing spondylitis.

Authors:  D H Oh; J B Jun; H T Kim; S W Lee; S S Jung; I H Lee; S Y Kim
Journal:  Clin Exp Rheumatol       Date:  2001 Mar-Apr       Impact factor: 4.473

3.  Adhesive arachnoiditis causing cauda equina syndrome in ankylosing spondylitis: CT and MRI demonstration of dural calcification and a dorsal dural diverticulum.

Authors:  I G Bilgen; N Yunten; E E Ustun; F Oksel; G Gumusdis
Journal:  Neuroradiology       Date:  1999-07       Impact factor: 2.804

4.  Arrested progression of the cauda equina syndrome of ankylosing spondylitis after lumboperitoneal shunting.

Authors:  A J Larner; H S Pall; A D Hockley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

5.  The neurological complications of ankylosing spondylitis.

Authors:  W B Matthews
Journal:  J Neurol Sci       Date:  1968 May-Jun       Impact factor: 3.181

6.  Magnetic resonance imaging of arachnoid diverticula associated with cauda equina syndrome in ankylosing spondylitis.

Authors:  M J Sparling; J D Bartleson; R A McLeod; M D Cohen; W W Ginsburg
Journal:  J Rheumatol       Date:  1989-10       Impact factor: 4.666

7.  Cauda equina syndrome complicating ankylosing spondylitis: MR features.

Authors:  D J Rubenstein; O Alvarez; B Ghelman; P Marchisello
Journal:  J Comput Assist Tomogr       Date:  1989 May-Jun       Impact factor: 1.826

8.  Cauda equina syndrome complicating ankylosing spondylitis: role of computed tomography and magnetic resonance imaging.

Authors:  R Westhovens; A Verstraeten; D Knockaert; M van Holsbeeck; A Sileghem; D Vanderschueren; J Dequeker
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

9.  MRI demonstration of arachnoiditis in cauda equina syndrome of ankylosing spondylitis.

Authors:  C H Charlesworth; L E Savy; J Stevens; B Twomey; R Mitchell
Journal:  Neuroradiology       Date:  1996-07       Impact factor: 2.804

10.  Cauda equina syndrome complicating ankylosing spondylitis.

Authors:  M J Mitchell; D J Sartoris; D Moody; D Resnick
Journal:  Radiology       Date:  1990-05       Impact factor: 11.105

View more
  10 in total

Review 1.  Cauda equina syndrome and dural ectasia: rare manifestations in chronic ankylosing spondylitis.

Authors:  C-C Liu; Y-C Lin; C-P Lo; T-P Chang
Journal:  Br J Radiol       Date:  2011-06       Impact factor: 3.039

Review 2.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

3.  Adalimumab Mitigates Lumbar Radiculopathy in a Case of Ankylosing Spondylitis.

Authors:  Trevor Persaud; Richard Morgan; Hein Linn Thant; Francis J DeAsis; Felix Ferre; Jose Diaz
Journal:  Am J Case Rep       Date:  2022-07-01

4.  Neurological complications of ankylosing spondylitis: neurophysiological assessment.

Authors:  Eman M Khedr; Sonia M Rashad; Sherifa A Hamed; Fatma El-Zharaa; Abdel Karim H Abdalla
Journal:  Rheumatol Int       Date:  2009-01-20       Impact factor: 2.631

5.  Destructive dural ectasia of dorsal and lumbar spine with cauda equina syndrome in a patient with ankylosing spondylitis.

Authors:  Marijke Van Hoydonck; Kurt de Vlam; Rene Westhovens; Frank P Luyten; Rik J Lories
Journal:  Open Rheumatol J       Date:  2010-08-26

6.  Symptomatic noncompressive motoromyelopathy presents as early manifestation in ankylosing spondylitis.

Authors:  Wei-Hsi Chen; Hsin-Ling Yin; Hung-Sheng Lin; Chung-Jen Chen
Journal:  Rheumatol Int       Date:  2010-11-02       Impact factor: 3.580

7.  Cauda equina syndrome associated with dural ectasia in chronic anlylosing spondylitis.

Authors:  Sang-Woo Ha; Byung-Chul Son
Journal:  J Korean Neurosurg Soc       Date:  2014-12-31

8.  Dural Ectasia and Cauda Equina Syndrome: A Rare Complication of Long-standing Fusion.

Authors:  Vrushali D Bachhav; Sumeet G Dua; Miral D Jhaveri
Journal:  Asian J Neurosurg       Date:  2018 Apr-Jun

9.  Evaluation of the Swallowing and Voice Functions in Ankylosing Spondylitis Patients.

Authors:  Esmail Abdulahi Ahmed; Sevgi Atar; Yavuz Atar; Hüseyin Sari; Melis Ece Arkan Anarat; Ziya Saltürk; Seyma Görcin Karaketir; Yavuz Uyar; Ömer Kuru
Journal:  Dysphagia       Date:  2021-07-14       Impact factor: 3.438

Review 10.  Transverse myelitis.

Authors:  Shin C Beh; Benjamin M Greenberg; Teresa Frohman; Elliot M Frohman
Journal:  Neurol Clin       Date:  2013-02       Impact factor: 3.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.